Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

Acquisitions (Tables)

12 Months Ended

Jun. 30, 2022

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

The aggregate purchase price of the acquisitions was allocated to the assets acquired and liabilities assumed based on their fair values as of the acquisition date. The following table summarizes the fair values of the assets acquired and liabilities assumed for the fiscal year 2021 acquisitions (in thousands):



	Asuragen		Eminence
Current assets, net of cash	$	10,422	$	3,145
Equipment and other long-term assets		3,762		1,639
Intangible assets:
Developed technology		107,000		6,778
In-process research and development		22,700		—
Customer relationships		11,700		2,133
Trade names		2,000		—
Non-competition agreement		1,000		—
Goodwill		90,563		7,848
Total assets acquired		249,147		21,543

Liabilities		4,963		1,436
Deferred income taxes, net		10,297		1,357
Net assets acquired	$	233,887	$	18,750

Cash paid, net of cash acquired		215,587		9,765
Contingent consideration payable		18,300		8,985
Net assets acquired	$	233,887	$	18,750